Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab
C. Rabascio, D. Laszlo, G. Andreola, L. Saronni, D. Radice, L. Rigacci, A. Fabbri, F. Frigeri, L. Calabrese, A. Billio, F. Bertolini, G. MartinelliVolume:
34
Year:
2010
Language:
english
Pages:
4
DOI:
10.1016/j.leukres.2009.07.002
File:
PDF, 212 KB
english, 2010